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Abstract
Motivation: Proteomic mass spectrometry analysis is becoming routine in clinical
diagnostics, for example to monitor cancer biomarkers using blood samples. How-
ever, differential proteomics and identification of peaks relevant for class separation
remains challenging.
Results: Here, we introduce a simple yet effective approach for identifying differen-
tially expressed proteins using binary discriminant analysis. This approach works
by data-adaptive thresholding of protein expression values and subsequent ranking
of the dichotomized features using a relative entropy measure. Our framework
may be viewed as a generalization of the ‘peak probability contrast’ approach of
Tibshirani et al. (2004) and can be applied both in the two-group and the multi-group
setting.
Our approach is computationally inexpensive and shows in the analysis of a
large-scale drug discovery test data set equivalent prediction accuracy as a random
forest. Furthermore, we were able to identify in the analysis of mass spectrometry
data from a pancreas cancer study biological relevant and statistically predictive
marker peaks unrecognized in the original study.
Availability: The methodology for binary discriminant analysis is implemented
in the R package binda, which is freely available under the GNU General Public
License (version 3 or later) from CRAN at URL http://cran.r-project.org/web/
packages/binda/. R scripts reproducing all described analyzes are available from
the web page http://strimmerlab.org/software/binda/.
Contact: k.strimmer@imperial.ac.uk
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1 Introduction
Mass spectrometry, a high-throughput technology commonly used in proteomics, en-
ables the measurement of the abundance of proteins, metabolites, peptides and amino
acids in biological samples. The study of changes in protein expression across subgroups
of samples and through time provides valuable insights into cellular mechanisms and
offers a means to identify relevant biomarkers, e.g, to distinguish among tissue types, or
for predicting health status. In practice, however, there still remain many analytic and
computational challenges to be addressed, especially in clinical diagnostics (Leichtle
et al., 2013).
A recent overview of statistical issues in the analysis of proteomics mass spectrom-
etry data is Morris (2012) who discusses a wide range of methods ranging from data
preprocessing, i.e. removal of systematic bias, peak identification, peak alignment and
quantification and calibration of relative peak intensities, to methods for high-level
statistical analysis, such as peak ranking and classification. Of particular importance is
the problem of differential protein expression and the identification of peaks informative
for group separation and class prediction.
A special characteristic of mass spectrometry data is their dual-valued nature, i.e.
they contain both continuous as well as discrete information. Specifically, a protein
may be differentially expressed if its intensity of expression varies among groups and is
relatively up- or down-regulated, or if a corresponding peak is either absent or present
in a specific group. Consequently, mass spectrometry intensity matrices typically contain
very large amounts of missing values, which renders application of standard statistical
methodology from other omics platforms, such as regularized t scores, difficult and
potentially suboptimal. Accordingly, this has initiated the development of new statistical
methodology (Tibshirani et al., 2004; Wang et al., 2012).
Two main strategies to address this issue in the high-level analysis of mass-spectrometry
data have emerged:
1. All data are treated as continuous, with missing intensity values set to zero or
imputed. Subsequently, standard omics methods are employed, such as t-scores
for feature selection (e.g. Datta and DePadilla, 2006).
2. The absence-presence data is used for data analysis in conjunction with the inten-
sity values. Tibshirani et al. (2004) propose peak probability contrasts (PPC), the
absolute difference in frequency of occurrence of a peak, for ranking and feature
selection, and also use PPC to improve absence-presence data by dichotomization
of intensity values. Wang et al. (2012) propose a test based on the PPC statistic and
propose to apply joint FDR control of the union of intensity-based and PPC-based
rankings.
Here, we follow the second route and propose a novel coherent model for differential
protein expression and prediction based on binary discriminant analysis. Our approach
may be viewed as a generalization of Tibshirani et al. (2004) and comprises the following:
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• The binary absence-presence data are explicitly modeled by a multivariate Bernoulli
distribution.
• Binary multi-group discriminant analysis (BinDA) is employed for feature ranking,
variable selection and prediction.
• For ranking of peaks the natural relative entropy variable importance measure
coherent with BinDA is used, rather than PPC.
• Likewise, for dichotomization of the intensity data matrix containing missing
values we employ the same entropy-based criterion.
As a result, we obtain simple principled framework for analyzing dual-valued mass
spectrometry data without the need for imputation, with a natural measure for variable
ranking and for differential protein expression, and with coherent prediction rules. In
contrast to many other methods this approach also allows multiple groups as response
variable, and thus extends beyond simple pairwise comparisons.
The remainder of the paper is structured as follows. Next, we describe in detail
the statistical methodology underlying BinDA. Then, for validation we investigate the
performance of the proposed approach in comparison with a random forest on a large-
scale chemometric data set. Subsequently, we present a detailed case study analyzing
mass spectrometry data from a pancreas cancer study. For reproducibility, we provide
the R package binda implementing our approach and R scripts for all analyzes described.
Finally, we discuss applicability of the BinDA approach to other molecular data as well
as further extensions.
2 Methods
2.1 Setup and notation
Our analysis starts after the raw mass spectrometry data have been adequately pre-
processed, i.e. transformed, smoothed, background-removed, calibrated, aligned, and
peak-extracted (e.g. Morris, 2012; Gibb and Strimmer, 2012).
We denote the resulting peak intensities by zij ≥ 0, with spectrum index i ∈
{1, . . . , n} and peak index j ∈ {1, . . . , d}. The data matrix zij typically contains missing
values as not all of the registered d peaks will be present in all of the n spectra. In
a classification setting each spectrum i also carries a class label yi ∈ {1, . . . ,K} that
assigns it to one of K different groups, for instance health status, tissue type, or treatment
outcome. The label is known for training data and unknown for test data. The sample
size in group with label y is ny with n = ∑Ky=1 ny.
From the continuous data zij we obtain binary peak intensities xij by thresholding at
peak-specific levels w = (w1, . . . ,wd). Specifically, we set xij = 1 if the peak is present
in sample i and zij ≥ wj. Conversely, if the peak is absent or zij < wj then xij = 0. The
methodology we present here uses the binary matrix xij for prediction and variable
ranking, rather than the original data zij, and it also estimates the thresholds w.
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2.2 Modeling binary data
Stochastic models for multivariate binary data are well established (e.g. Dai et al., 2013;
Cox, 1972). A univariate binary random variable X ∼ Be(µ) with two states x=0 and x=1
is completely described by a Bernoulli distribution Be(µ) with expectation E(X) = µ
and variance Var(X) = µ(1− µ).
In the multivariate case this generalizes to X = (X1, . . . ,Xd) ∼ Bed(µ, ζ) where d
denotes the dimension of the multivariate Bernoulli (MVB) distribution, µ = (µ1, . . . , µd)
is the vector of expectations E(X) = µ, and ζ contains the 2d − d− 1 interaction parame-
ters. As in the univariate case the variances Var(Xj) = µj(1− µj) are fully determined
by the means.
In many cases it is useful to ignore the dependencies among the individual variables
Xj in order to reduce the number of parameters in the model. Despite, or perhaps
because, of its simplicity the independence “naive Bayes” assumption can be very
effective, especially for prediction in high dimensions and small sample size, see Hand
and Yu (2001); Park (2009). For MVB with independent predictor variables the joint
probability mass function is given by
Pr(x) =
d
∏
j=1
{
1− µj if xj = 0,
µj if xj = 1.
with diagonal covariance matrix Var(X) = diag{µj(1− µj)}.
2.3 Discriminant analysis with binary predictors
For prediction of the class associated with an unlabeled spectrum we need to construct a
prediction rule. Here we employ a Bayesian prediction rule similar as in diagonal dis-
criminant analysis (DDA) that is routinely and successfully used, e.g., in transcriptomics
(Tibshirani et al., 2003). We call this approach binary discriminant analysis (BinDA).
We first define group-specific models for each group with label y,
Pr(x|y) =
d
∏
j=1
{
1− µyj if xj = 0,
µyj if xj = 1.
(1)
For each group y we also specify a prior probability Pr(Y = y) = piy with ∑Ky=1 piy = 1.
By µ0j = ∑Ky=1 piyµyj we denote the pooled mean for each variable j, i.e. the mean we
would assign if there was only a single category.
The posterior probability of each group is then given by Bayes’ theorem Pr(y|x) =
Pr(x|y)piy/Pr(x) which after taking the logarithm yields the discriminant function
dy(x) = log Pr(y|x) = logpiy + log Pr(x|y) + C . (2)
As the purpose of dy(x) is only to compare among different groups we can drop all
terms that do not depend on y, such as Pr(x), represented above by the constant C.
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Prediction of a label for test data x is carried out by choosing the group y that maximizes
the discriminant function,
yˆ = arg max
y
dy(x)
This MVB independence prediction rule has shown to be highly effective (e.g. Park,
2009), even if there is correlation among predictors.
Typically, the parameters of discriminant function are unknown themselves and
have to be learned themselves from training data, i.e. from spectra with known group
labels. The training is done by estimating the means µyj and the group probabilities piy
in Eq. 1 and Eq. 2. We suggest a flexible estimation strategy by employing maximum
likelihood estimation for large sample size, and otherwise using regularized estimation.
For instance, to estimate the group probabilities we use observed frequencies pˆiy = ny/n
if n is large, and for small n the Stein-type shrinkage estimator of proportions described
in Hausser and Strimmer (2009).
2.4 Variable ranking and selection
Closely tied in with prediction is the question which variables are most important for
successful assignment of a class label, and, conversely, which variables are irrelevant.
Especially in large-dimensional problems it is very important to remove the null features
as the build-up of random noise from these variables can substantially degrade the
overall prediction accuracy (cf. Ahdesmäki and Strimmer, 2010).
For ranking features in discriminant analysis with binary variables there have been
many, in part contradictory, propositions. For the case of K = 2 groups the following
criteria, among others, have been used:
• The chi-square statistic of independence between response and predictors (An
et al., 2013),
• peak probability contrasts |µy1 − µy2| (Tibshirani et al., 2004),
• Quinlan’s information gain measure (Bender et al., 2004), and
• ratio of between-group and within-group covariance (Wilbur et al., 2002).
See Tan et al. (2004) for many other proposals for measuring associations between
categorical outcomes and binary variables. Only some of the criteria above can also be
applied to the multiple group case (K > 2).
We use a principled approach to variable ranking relying on predictive informa-
tion, see Gelman et al. (2014) for an overview. Conceptually, we use the expected
log-predictive density as measure of model fit, and compare the fully specified joint
model containing all predictors and the response with a “no-effects” model where the
response is independent of the predictors. The difference of expected log-likelihood
between full and “no-effects” model is given by the relative entropy or Kullback-Leibler
divergence D = KL(Ffull||Fno-eff). The relative contributions of each individual predictor
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to D then provides a measure of variable importance. This procedure applied to linear
regression with independent predictors results in squared marginal correlations, and
applied to diagonal discriminant analysis it yields squared t-scores, both of which are
optimal measures for variable ranking in their respective settings (Zuber and Strimmer,
2011).
For independent binary predictors the joint full model is
Pr(x, y)full =
d
∏
j=1
{
(1− µyj)piy if xj = 0,
µyjpiy if xj = 1
whereas the no-effects model is
Pr(x, y)no-eff =
d
∏
j=1
{
(1− µ0j)piy if xj = 0,
µ0jpiy if xj = 1.
This results in
D =
d
∑
j=1
K
∑
y=1
(
µyjpiy log
(
µyj
µ0j
)
+ (1− µyj)piy log
(
1− µyj
1− µ0j
))
=
d
∑
j=1
K
∑
y=1
piy KL
(
Be(µyj)||Be(µ0j)
)
≈
d
∑
j=1
1
2
K
∑
y=1
piy
(
µyj − µ0j
σj
)2
=
d
∑
j=1
Sj
(3)
where σ2j = µ0j(1− µ0j) is the variance of Be(µ0j). For the special case of K = 2 groups
Sj simplifies to
Sj(K=2) =
pi1pi2
2
(
µ1j − µ2j
σj
)2
.
By construction, the score Sj is a measure of variable importance of feature j where
Sj is a weighted sum of the squared z-scores that compare each group mean with the
overall pooled mean. This is precisely analogous to the pooled-mean formulation of
discriminant analysis described in Ahdesmäki and Strimmer (2010). If the variances
σ2j are similar across features, then Sj(K=2) is apart from a scale factor the squared peak
probability contrast.
As above for learning the discriminant function, we use for estimation of the entropic
ranking scores Sj either maximum likelihood or shrinkage estimates of proportions,
depending on sample size.
Noting that npˆiy/(1− pˆiy) = (1/ny− 1/n)−1 we may also introduce squared t-scores
t2y0 = n
pˆiy
1− pˆiy
(
µˆyj − µˆ0j
σˆj
)2
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that are properly scaled to allow to contrast the individual contributions of each class
relative to each other, similar as in the methods described in Ahdesmäki and Strimmer
(2010) and Tibshirani et al. (2003). The estimated ranking score may also be expressed in
terms of a weighted sum of the t-scores via
Sˆj =
K
∑
y=1
(1− pˆiy)t2y0/(2n) .
After ranking variables according to the estimated scores Sˆj, with highest scores indicat-
ing the most relevant predictors, we use cross-validation to evaluate prediction accuracy
for different numbers of included predictors to determine a suitable cutoff.
2.5 Dichotomization
With the above setup for BinDA it is straightforward to perform dichotomization. Specifi-
cally, we choose thresholds w = (w1, . . . ,wd) to discretize the continuous data zij to max-
imize the entropy score D (Eq. 3). As in our model assume the predictors are assumed
to be independent we can optimize each threshold wj independently by maximizing
the individual Sj. Note that the same entropy measure is used both for determining the
thresholds and for ranking the predictors, thus ranking and discretization is done in an
integrative fashion.
3 Results
3.1 Implementation and reproducible research
We have implemented our approach for multi-class discriminant analysis using binary
predictors including functions for variable ranking and dichotomization in the R package
binda that is freely available under the GNU General Public License (version 3 or later)
from URL http://cran.r-project.org/web/packages/binda/. For reproducibility of
the analyzes presented in this paper we provide corresponding R scripts at http://
strimmerlab.org/software/binda/.
3.2 Validation of binda
Binary discriminant analysis (BinDA) has been studied extensively and is well estab-
lished in the literature (e.g. Cox, 1972). More recently, it was demonstrated that BinDA
with naive Bayes assumption can yield high rates of predictive accuracy even if the
underlying assumption of independence of predictors is not met (An et al., 2013; Park,
2009; Bender et al., 2004; Wilbur et al., 2002).
For validation of our implementation of BinDA in the R package binda we analyzed
a large-scale chemometric test data set. Specifically, we investigated the “Dorothea” drug
discovery data set from the NIPS 2003 feature selection challenge (Guyon et al., 2005).
The data set contains d = 100, 000 binary features describing the three-dimensional
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properties of chemical compounds that either bind (response label +1) or not (label -1) to
thrombin, an enzyme involved in blood clotting.
We used the “Dorothea” training data with ntrain = 800 samples and corresponding
class labels to learn a classifier with binda. Subsequently, we applied the resulting
classification rule to the validation data set with nval = 350 samples and predicted the
sample labels of the validation data. As for the validation data the true labels are known
we were then able to compute the actual prediction accuracy, i.e. the proportion of
correctly identified labels.
Due to its algorithmic simplicity training the classifier and ranking variables with
bindawas computationally inexpensive. Applying class-balanced 5-fold cross-validation
with 20 repetitions using the R package crossval on the training data alone we deter-
mined that the response can be predicted well with only very few top ranking predictors
included in the classification rule. For instance, a binda classifier with 3 predictors
yielded prediction accuracy on the validation set of 0.9371 and of 0.9429 if 10 predictors
were used. The predictive accuracy without any variable selection including all 100,000
predictors was 0.9057.
For comparison we also trained a random forest (Breiman, 2001), a tree-based ma-
chine learning approach that emerged as one of the overall best performing methods for
classification in a recent systematic study (Fernández-Delgado et al., 2014). Due to the
high-dimensionality the running time for learning the random forest from the training
data was two magnitudes slower than binda, taking 652 seconds on our workstation in
comparison to 5 seconds for binda. The random forest yielded an accuracy of 0.94 for
prediction of the labels of the independent validation data set. This analysis confirms
that BinDA, though very simple, is able, at least for this data, to perform prediction as
accurately as random forest. Correspondingly, if variables in the random forest were
ranked according to the Gini variable importance measure the top-ranking features were
mostly identical to those ranked best by BinDA, which indicates that BinDA is indeed
able to select the most relevant variables.
3.3 Analysis of pancreas cancer proteomics data
3.3.1 Pancreas cancer study
For illustration of our proposed approach to classification and peak ranking in mass
spectrometry data we also reanalyzed experimental proteomics data from a pancreas
cancer study conducted in Leipzig and Heidelberg (Fiedler et al., 2009). For the training
data set of this study 40 patients with diagnosed pancreas cancer as well as 40 healthy
controls were recruited. Each participant of the study donated serum samples which
provided the basis for MALDI/TOF measurements. For each sample 4 technical repli-
cates were obtained. Due to the presence of strong batch effects in our analysis below
we restrict ourselves to patients and controls from Heidelberg, leading to a raw data set
containing 160 spectra for 40 probands,
The aim of the study was to determine biomarkers to discriminate patients with
pancreas cancer from healthy persons. Fiedler et al. (2009) found marker peaks at m/z
9
3884 (double charged) and 7767 (single charged) and correspondingly supposed platelet
factor 4 (PF4) as potential marker, arguing that PF4 is down-regulated in blood serum of
patients with pancreatic cancer.
3.3.2 Preprocessing and dichotomization
For preprocessing of the raw mass spectrometry data we employed the standard anal-
ysis pipeline implemented in the R package MALDIquant (Gibb and Strimmer, 2012).
Specifically, the raw data were variance-stabilized, smoothed, baseline-corrected, TIC-
standardized, and aligned. Technical replicates were then averaged, peaks were iden-
tified and corresponding intensities extracted from each averaged spectrum. Precise
details on the preprocessing can be found in the R script. As a result a protein expression
matrix of size 40 patients times 166 peaks was obtained. In total 26% of intensities in the
matrix were missing, corresponding to about 44 missing peaks per spectrum.
Subsequently, we performed dichotomization of the intensity matrix using the rel-
ative entropy criterion of Eq. 3. To illustrate the improvement of the resulting binary
data matrix over the original absence-presence matrix we conducted hierarchical clus-
tering on the samples. As can be seen in Fig. 1 the clustering based on the optimized
binary matrix almost perfectly separates pancreas cancer samples from healthy samples,
indicating that there is a strong signal in the data.
3.3.3 Peak ranking and differential expression thresholds
In order to identify features responsible for the separation of cancer versus healthy
samples in Fig. 1 B we applied peak ranking for binary data according to BinDA. The
resulting ranking of the 30 best discriminating peaks is shown in Fig. 2. As a consequence
of the discrete data, the first three top-ranking peaks with m/z values 4495, 8868, and
8989) achieved the same maximum score, followed by the next three peaks 1855, 4468,
and 8937, that also achieved an identical score.
We note that none of these peaks were identified in the original study. The two
PF4 peaks with m/z 3884 and 7768 (the slight difference is due to the MALDIquant
alignment procedure) rank on places 148-151 and 157-163, respectively.
Using cross-validation we estimated prediction errors for group separation from the
binary data matrix. As for the “Dorothea” data set we employed class-balanced 5-fold
cross-validation with 20 repetitions. Interestingly, using only 5 predictors was sufficient
to achieve an accuracy of 0.96, sensitivity of 0.96, specificity of 0.97, positive predictive
value of 0.97 and negative predictive value of 0.95. This indicates that the observed clear
separation between cancer and control samples in Fig. 1 B is attributable to only very
few features of the data.
Visual inspection of the group of top-ranking differentially expressed peaks revealed
a further pattern (Fig. 3). First, five of the peaks are all part of the same peak group.
Second, the peak group appears both in a single charged (m/z 8868, 8937, 8989) version
as well as in a mirrored double charge version (m/z 4468 and 4495). This affirms that
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B) Dichotomized Data
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Figure 1: Clustering of samples from the pancreas cancer study of Fiedler et al. (2009)
using (A) the original absence-presence data and (B) the optimized binary matrix. Filled
circles indicate pancreas cancer samples, empty circles healthy controls. For clustering
we employed Ward’s agglomerative hierarchical clustering based on a Jaccard distance
matrix computed using R standard functions hclust() with method="ward.D2" and
dist() with method="binary".
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Figure 2: Ranking of 166 peaks in the preprocessed spectra from the pancreas cancer
study according to BinDA framework.
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Figure 3: Top ranking peak group containing 5 differentially expressed peaks: (A)
double- and (B) single-charged peaks.
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Figure 4: Densities of expression values and estimated thresholds for the top ranking
peaks. Each column shows the single charged (bottom row) and the corresponding
double charged variant (top row).
there must a underlying biological marker driving the observed changes between cancer
and control samples.
To study this further, we inspected the intensities for the peaks belonging to the
differentially expressed peak group. Fig. 4 shows the overall density, as well as the sub-
density for the cancer samples, along with the dichotomization threshold estimated by
binda. For all five peaks the expression respectively the underlying protein abundance
is up-regulated in the cancer samples compared with the controls. In addition, the
estimated thresholds provide an effective means to separate the two groups.
3.3.4 Biological relevance
Finally, we also tried to identify the biological molecules behind the differentially ex-
pressed peak group shown in Fig. 3. Specifically, we used the TagIdent tool (Gasteiger
et al., 2005) with settings Mw 8936.97, Mw range 0.05% and organism homo sapiens
to query the UniProtKB/Swiss-Prot data base (The UniProt Consortium, 2015). This
indicated a potential link of the central peak m/z 8937 to PDPFL_HUMAN, the pan-
creatic progenitor cell differentiation and proliferation factor-like protein, as well as to
a fragment of C3adesArg, an acylation stimulating protein. The increased abundance
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of PDPFL_HUMAN in pancreas cancer tissue appears highly plausible, and the in-
creased concentration of C3adesArg in serum of cancer patients has also been reported
previously (e.g. Opstal-van Winden et al., 2011).
Another biologically relevant result of our analysis based on BinDA is that the
originally proposed PF4 marker is not differentially expressed and hence cannot be used
to distinguish between cancer and healthy samples.
4 Discussion
We have presented a simple yet effective approach to differential expression and classifi-
cation for mass spectrometry data using binary discriminant analysis. Our approach
may be viewed as generalization of Tibshirani et al. (2004) and can be applied also for
multi-group discriminant analysis. A particular feature is the use of the same relative
entropy criterion for peak ranking and selection and for dichotomization of the continu-
ous protein intensity data. In addition, we obtain decision thresholds from the protein
intensities that are biologically and diagnostically easy to interpret.
In illustrative analysis of high-dimensional drug discovery data we showed that
our approach implemented in the R package binda is computationally effective and
yet competitive with a random forest. Furthermore, in reanalysis of proteomics data
from a pancreas cancer study we found statistically predictive marker peaks to tumor
cell growth unrecognized in the original analysis. This confirms the importance of
reproducible research in proteomics, where it is unfortunately still not common to
provide analysis scripts and software openly.
In addition to mass spectrometry analysis, there are many bioinformatics applications
in which binary data are collected, and hence in which the present methodology and
software will potentially be useful. Examples include meta-genomics, where the absence
and presence of proteins and genes is compared to a pan-genome (Medini et al., 2008),
community analysis by DNA fingerprinting (Wilbur et al., 2002), and chemometrics
(Bender et al., 2004).
Exploring additional applications may also lead to further methodological extensions
of the procedures currently implemented in binda, such as modeling overdispersion,
e.g., by employing the Beta-Bernoulli rather than Bernoulli distribution, and to take
account of interactions among predictors, e.g., by modeling pair-wise correlation.
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